Therapy of multiple myeloma and monitoring of the response
Rapazzini, P.; Bettini, R.; Masini, M.; Steidl, L.; Ferrari, V.; Piantanida, S.
Recenti Progressi in Medicina 77(2): 95-99
1986
ISSN/ISBN: 0034-1193 PMID: 3715177 Document Number: 276829
Document emailed within 1 workday
Related Documents
Riccardi, A.; Montecucco, C.; Merlini, G.; Ucci, G.; Cremonini, N.; Gobbi, P.G.; Ascari, E. 1984: Proliferative activity, response to therapy and survival in multiple myeloma Haematologica 69(2): 148-162Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Udd, K.A.; Spektor, T.M.; Berenson, J.R. 2017: Monitoring multiple myeloma Clinical Advances in Hematology and Oncology: H&o 15(12): 951-961
Neuwirtová, R.; Stĕpán, J.; Pacovský, V.; Formánková, J.; Jarolímková, E. 1983: Biochemical monitoring of bone involvement in multiple myeloma Vnitrni Lekarstvi 29(7): 630-637
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Hartman, H.A.; Skoog, D.; Foley, J.F.; Stone, D.B. 1979: Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis Nebraska Medical Journal 64(7): 201-205
Clavio, M.; Casciaro, S.; Gatti, A.M.; Spriano, M.; Bonanni, F.; Poggi, A.; Vallebella, E.; Pietrasanta, D.; Prencipe, E.; Goretti, R.; Vimercati, R.; Rossi, E.; Masoudi, B.; Ghio, R.; Boccaccio, P.; Ricciardi, S.; Damasio, E.; Gobbi, M. 1996: Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients Haematologica 81(3): 238-244
Dogaru, M.; Lazăr, V.; Coriu, D. 2012: Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases Roumanian Archives of Microbiology and Immunology 71(4): 183-200
Mokeeva, R.A.; Khokhlova, M.P.; Kozinets, G.I.; Zhuravlev, V.S.; Rybakova, M.E. 1986: Characteristics of various immunochemical forms of multiple myeloma in relation to mortality and response to treatment Gematologiia i Transfuziologiia 31(7): 7-13
Izumi, T. 2014: Novel targeted therapy in multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 72(6): 1089-1093
Avvisati, G.; Pulsoni, A.; Petrucci, M.T.; Tribalto, M. 1990: Therapy of multiple myeloma and its complications Recenti Progressi in Medicina 81(10): 642-650
Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56
Fiorini, F.; Napoli, S.; Giordano, L.; Castelluccio, A. 1995: Renal involvement in multiple myeloma. Physiopathology and therapy Minerva Urologica e Nefrologica 47(3): 125-131
Bessmel'tsev, S.S.; Abdulkadyrov, K.M. 2002: Results, failures and perspectives in therapy of multiple myeloma Voprosy Onkologii 48(2): 146-152
Górski, J.; Kicińska, M. 1990: Combined therapy of multiple myeloma: cytostatics and plasmapheresis Acta Haematologica Polonica 21(2): 166-172
Peest, D. 1998: Prognostic factors and standard therapy of multiple myeloma Praxis 87(25-26): 874-878
Locatelli, F.; Giovanelli, E.; Neretto, G.; Furno, F.; Pellerito, R. 1979: Survival and therapy of multiple myeloma. Apropos of 56 observed cases Minerva Medica 70(13): 925-933
Gieseler, F.; Nüssler, V. 1998: Cellular resistance mechanisms with impact on the therapy of multiple myeloma Leukemia 11(Suppl): S1-S4
Kyle, R.A. 1999: Maintenance therapy and supportive care for patients with multiple myeloma Seminars in Oncology 26(5 Suppl 13: 35-42
Yamazaki, K. 1970: Drug therapy of multiple myeloma--various factors influencing the effects of drugs Gan no Rinsho. Japan Journal of Cancer Clinics 16(9): 889-895